Get the Stockscreener App
10.50
0.28%
-0.03
Daxor Corporation stock is traded at $10.50, with a volume of 1,188.
It is down -0.28% in the last 24 hours and down -0.94% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$10.53
Open:
$10.102
24h Volume:
1,188
Relative Volume:
0.16
Market Cap:
$61.30M
Revenue:
$503.40K
Net Income/Loss:
$9.17M
P/E Ratio:
5.7982
EPS:
1.8109
Net Cash Flow:
$-604.40K
1W Performance:
+1.99%
1M Performance:
-0.94%
6M Performance:
-26.32%
1Y Performance:
+6.49%
1-Day Range:
$10.05
$10.50
1-Week Range:
$10.05
$10.53
52-Week Range:
$8.56
$14.76
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.50 | 61.48M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
426.08 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.25 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.97 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.11 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.78 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Daxor to exhibit blood volume analyzer at dysautonomia conference By Investing.com - Investing.com Canada
Daxor debuts Blood Volume Analyzer at dysautonomia conference - Stock Titan
DXRDaxor Corp Options - Finviz
Avoiding Lag: Real-Time Signals in (DXR) Movement - Stock Traders Daily
Daxor Corporation (DXR) Edges Higher, Testing Key Resistance ZoneAdvance Decline Volume - dars.gov.et
Enterprise value to EBITDA forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to sales forward of Daxor Corporation – FWB:DX5 - TradingView
Price to book forward of Daxor Corporation – FWB:DX5 - TradingView
Enterprise value to revenue forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBIT forward of Daxor Corporation – NASDAQ:DXR - TradingView
Price to earnings forward of Daxor Corporation – NASDAQ:DXR - TradingView
Enterprise value to EBITDA forward of Daxor Corporation – FWB:DX5 - TradingView
Daxor Corporation (DXR) Edges Lower, Testing Support Levels Near $10.25Market Profile - dars.gov.et
DX5 Forecast — Price Target — Prediction for 2027 - TradingView
Daxor Corporation Actuals & Estimates (NASDAQ:DXR) - TradingView
DXR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Daxor Corp For: 25 June By Investing.com - Investing.com South Africa
Daxor (DXR) CFO receives 12,000-share stock grant, now holds 33,050 - Stock Titan
DAXOR (DXR) CEO receives 30,000-share equity grant, now holds 243,694 - Stock Titan
Daxor (DXR) Chief Scientific Officer receives 25,000-share stock grant - Stock Titan
Daxor (DXR) director granted 2,500 stock options at $10.14 - Stock Titan
Daxor (DXR) director awarded 2,500 stock options at $10.14 strike - Stock Titan
DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike - Stock Titan
DAXOR (DXR) director awarded 2,500 stock options at $10.14 strike price - Stock Titan
Daxor Shareholders Reelect Board and Ratify Auditor - The Globe and Mail
Daxor Corporation 8-K Filing June 2026: Shareholder Vote Results, Nasdaq Listing, and Company Details - Minichart
Daxor (NASDAQ: DXR) investors reelect full board and ratify Bush & Associates as auditor - Stock Titan
Number of shareholders of Daxor Corporation – BOATS:DXR - TradingView
Daxor Corporation (DXR) Holds Near Support After Modest DeclineAdaptive Moving Average - dars.gov.et
Discipline and Rules-Based Execution in DXR Response - Stock Traders Daily
Daxor (DXR) Proxy Filing Summary - Quartr
Daxor (DXR) Q4 2025 earnings summary - Quartr
Daxor (DXR) Q2 2024 earnings summary - Quartr
Daxor (DXR) Corporate Presentation Summary - Quartr
Daxor (DXR) Q4 2024 earnings summary - Quartr
Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Daxor Corp (DXR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Daxor Corp (DXR) Institutional Confidence - TradingKey
Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Daxor Corp (DXR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daxor Corp (DXR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Behavioral Patterns of DXR and Institutional Flows - Stock Traders Daily
Daxor Corporation (DXR) Declines 4.39%: Approaching Key Support Near $10.07PCR Moving Average - newsline.com
Daxor Corporation (DXR) Q3 2007 Earnings: EPS Surges 325% Above Estimates, Stock Declines Despite Beat - newsline.com
Daxor (DXR) plans June 23, 2026 vote on directors and auditor - Stock Titan
Daxor (DXR) Proxy filing Summary - Quartr
Daxor (DXR) Secures Patent for Innovative Blood Volume Monitorin - GuruFocus
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor - GlobeNewswire
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Daxor Corporation Stock (DXR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer |
Mar 31 '26 |
Buy |
9.90 |
1,000 |
9,900 |
21,050 |
2.39%
2.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):